We are a team with a singular shared goal: to improve patient outcomes.

“We are thrilled to have led an investment in Tempus... Given NEA's long and successful history investing in the intersection of technology and life science, we felt like the perfect strategic partner given Tempus' mission to help doctors personalize care by collecting and analyzing large volumes of data.”

“Having spent my entire career at the forefront of emerging technologies, it’s exciting to see how healthcare is finally embracing the very technologies that have transformed so many other industries. This is a space that is near and dear to Jean and I, and we're excited to have invested in Tempus as they seek to bring big data, artificial intelligence and advanced molecular analysis to those suffering with cancer and other life threatening diseases.”

“Nowhere is technology more desperately needed than in healthcare. As a country, we spend over three trillion dollars annually. We have a social and economic imperative to improve our healthcare system: to make it better, more accessible, and more effective. I'm thrilled to have invested in Tempus and their team of innovators who are obsessed with developing breakthroughs in how we treat diseases.”